Hologic, Inc. (NASDAQ:HOLX) Q1 2024 Earnings Call Transcript

Ryan Simon : Hey, Cynthia, this is Ryan, in consideration of time, we’ll take one final question.

Operator: And we’ll go next to Navann Ty with BNP.

Navann Ty: Hi, thank you for taking my question, good evening. Maybe my first question if you can discuss your AI capabilities versus competition, including with breast health versus recent innovation like competitors. And a second question, following up on your comments regarding the [inaudible] international that you’re meeting. Can you discuss the size of the long term opportunity outside of the US and any potential structural differences?

Steve MacMillan: Yes, I think, relative to the AI front, as it relates to Breast health, we’ve been, on the leading edge for quite some time between our CAD programs and A, the Genius AI Detection program. So we continue to feel very good, particularly as it relates to the workflow advantages, and the linkage to our workstations and our products. And on the second question of international, I think, again, we’ve been generating, frankly, double digit growth for our international business for the better part, yes, excluding COVID-ish for last five or six years, and continue to see international being accretive to our overall growth rate here for years to come. So thank you very much.

Operator: This concludes today’s question and answer session. And this now concludes Hologic’s First Quarter Fiscal 2024 Earnings Conference Call. Thank you and have a good evening.